{
    "title": "103_hr5056",
    "content": "The Act may be cited as the \"Animal Drug Amendments of 1994\" and addresses unapproved uses. The \"Animal Drug Amendments of 1994\" address unapproved uses of new animal drugs, stating that if an application is approved for a specific use, the drug is exempt from certain requirements for a different use if prescribed by a licensed veterinarian in a veterinarian-client-patient relationship. The \"Animal Drug Amendments of 1994\" allow for different uses of animal drugs if prescribed by a licensed veterinarian in a veterinarian-client-patient relationship and in compliance with regulations set by the Secretary. If there is a risk to public health, the Secretary may establish safe residue levels for such different uses. The Secretary may establish safe residue levels for different uses of animal drugs authorized by veterinarians to ensure public health safety. Access to veterinarians' records may be provided to monitor authorized drug uses that pose a risk to public health. The Secretary may prohibit the use of an animal drug if it poses a risk to public health or if required analytical methods have not been submitted. Approved drugs under section 505 are exempt from certain safety requirements if used by a licensed veterinarian in a veterinarian-client-patient relationship. The Secretary can prohibit animal drug use for public health risks or lack of required analytical methods. Approved drugs under section 505 are exempt from safety requirements when used by a licensed veterinarian in a veterinarian-client-patient relationship. Amendments to the Federal Food, Drug, and Cosmetic Act include regulations for drug use in animals and violations of specific sections. The Secretary of Health and Human Services will promulgate regulations within 2 years of the enactment of the Act to implement specific sections of the Federal Food, Drug, and Cosmetic Act related to animal drug use. The amendments made by this section will take effect upon the adoption of final regulations."
}